Description
CK-MB/cTnI/H-FABP Fast Test Kit (Immunofluorescence Assay)
The CK-MB/cTnI/H-FABP Fast Test Kit is a quantitative, in vitro diagnostic tool for detecting cardiac biomarkers in serum, plasma, or whole blood. Utilizing advanced immunofluorescence technology, this test aids in the early diagnosis and prognosis of myocardial injury, including Acute Myocardial Infarction (AMI), Unstable Angina, Myocarditis, and Acute Coronary Syndrome (ACS).
Why Choose This Test?
- Rapid results: Provides results in just 10 minutes
- Comprehensive panel: Simultaneous detection of CK-MB, cTnI, and H-FABP
- High sensitivity: Effective even in early stages of cardiac events
- Easy sample collection: Accepts serum, plasma, or whole blood
- Wide detection ranges:
- CK-MB: 2.5–80.0 ng/ml
- cTnI: 0.1–50.0 ng/ml
- H-FABP: 2.0–100.0 ng/ml
Key Biomarkers Explained
- CK-MB: Highly specific marker for cardiac muscle injury
- cTnI: A gold standard biomarker for detecting myocardial infarction
- H-FABP: Ultra-sensitive early marker, detectable within 30 minutes of cardiac ischemia
Specifications
| Parameter | Details |
|---|---|
| Sample Types | Serum, Plasma, Whole Blood |
| Detection Method | Immunofluorescence Assay |
| Test Time | 10 Minutes |
| Cut-off Values | CK-MB: 5.0 ng/ml, cTnI: 0.1 ng/ml, H-FABP: 6.36 ng/ml |
| Storage | 4–30°C |
| Shelf Life | 24 Months |
Compatible Devices
- Getein 1100 Immunofluorescence Quantitative Analyzer
- Getein 1600 Immunofluorescence Quantitative Analyzer
Clinical Applications
- Early diagnosis of myocardial infarction and ACS
- Assessment of chest pain and myocardial injury
- Monitoring treatment effectiveness and risk stratification
